By adding optical imaging to a uPAR-targeted strategy we demonstrated bridging of the gap between preoperative uPAR-PET imaging for tumor assessment and planning, and intraoperative optical guidance for tumor detection, delineation and resection, based on ligands with an identical binding domain directed against the same oncotarget. The gene discussed is PLAUR; the disease is neoplasm.